Edition:
United Kingdom

Editas Medicine Reports Data Demonstrating Subretinal Injection Of Edit-101 Well-Tolerated In Non-Human Primates


Friday, 18 May 2018 

Editas Medicine Inc ::EDITAS MEDICINE REPORTS DATA DEMONSTRATING SUBRETINAL INJECTION OF EDIT-101 WELL-TOLERATED IN NON-HUMAN PRIMATES.EDITAS MEDICINE INC - BOTH EDIT-101 AND VIR-067 WERE WELL TOLERATED IN ANIMALS TREATED WITH PROPHYLACTIC STEROIDS.EDITAS MEDICINE INC - EDITAS MEDICINE AIMS TO FILE AN INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR EDIT-101 BY MID-2018. 

Company Quote

25.8
0.08 +0.31%
18 Apr 2019